Upregulation of Antioxidant Capacity and Nucleotide Precursor Availability Suffices for Oncogenic Transformation
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
SUMMARY The emergence of cancer from diverse normal tissues is thought to be governed by a common set of fundamental processes. However, these processes are not fully defined. Here, we show that forced expression of glucose-6-phosphate dehydrogenase (G6PD) affords immortalized mouse and human cells anchorage-independent growth in vitro and tumorigenicity in animals. Mechanistically, G6PD augments NADPH levels by simulating NAD+ kinase-mediated biosynthesis of NADP+ besides converting NADP+ to NADPH, bolstering antioxidant defense. G6PD also increases intracellular nucleotide precursor levels through the production of ribose and NADPH, promoting cell proliferation. Supplementation of antioxidants or nucleosides suffices to convert mouse and human cells into a tumorigenic state in vitro and in animals, and supplementation of both is required when their overlapping metabolic consequences are minimized. These results suggest that normal cells have a limited capacity for redox balance and nucleotide synthesis, and overcoming this limit might represent a key aspect of oncogenic transformation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 1×
“A widespread trait of tumor cells, which is brought about directly or indirectly by oncogenic mutations, is the reprogramming of cellular metabolism (Cairns et al., 2011; DeBerardinis and Chandel, 2016; Pavlova and Thompson, 2016; Vander Heiden et al., 2009; Vander Heiden and DeBerardinis, 2017; Zhu and Thompson, 2019…”
BackgroundRegulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744 · cited 1×
“A widespread trait of tumor cells, which is brought about directly or indirectly by oncogenic mutations, is the reprogramming of cellular metabolism (Cairns et al., 2011; DeBerardinis and Chandel, 2016; Pavlova and Thompson, 2016; Vander Heiden et al., 2009; Vander Heiden and DeBerardinis, 2017; Zhu and Thompson, 2019…”
BackgroundFundamentals of Cancer Metabolism
DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013 · cited 1×
“A widespread trait of tumor cells, which is brought about directly or indirectly by oncogenic mutations, is the reprogramming of cellular metabolism (Cairns et al., 2011; DeBerardinis and Chandel, 2016; Pavlova and Thompson, 2016; Vander Heiden et al., 2009; Vander Heiden and DeBerardinis, 2017; Zhu and Thompson, 2019…”
BackgroundCreation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Signal transduction by reactive oxygen species
Finkel, T. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201102095 · Cited by 2,322 · cited 1×
“ROS have long been thought to aid in tumor initiation and progression by accelerating genetic mutations, inducing inflammation, and/or activating proliferative pathways (Finkel, 2011).”
BackgroundOncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020 · cited 1×
“G6PD is regulated by various oncogenes and tumor suppressors including ATM, NRF2, mTORC1, TAp73, and p53 (Cosentino et al., 2011; Du et al., 2013; Duvel et al., 2010; Jiang et al., 2011; Jiang et al., 2013b; Mitsuishi et al., 2012) and is implicated in the pathogenesis of human cancers (Patra and Hay, 2014; Stincone e…”
BackgroundWise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001 · cited 3×
“2014), while markedly increases glutaminolysis that traverses through the mitochondrial malic enzyme ME2 (Wise et al., 2008).”
BackgroundGlutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990 · cited 3×
“, 2012), while promoting glutamine flux through the cytoplasmic malic enzyme ME1 (Son et al., 2013).”
BackgroundKlein, E. A., Thompson, I. M., Tangen, C. M., Crowley, J. J., Lucia, M. S., Goodman, P. J., Minasian, L. M., Ford, L. G., Parnes, H. L., Gaziano, J. M., et al. (2011) · JAMA · doi:10.1001/jama.2011.1437 · Cited by 1,787
Cited by
Cancer metabolism: looking forward
Martínez-Reyes, I., & Chandel, N. S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00378-6 · Cited by 1,824
The role of ROS in tumour development and progression
Cheung, E. C., & Vousden, K. H. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-021-00435-0 · Cited by 1,595
Rajput, V. D., Harish, Singh, R. K., Verma, K. K., Sharma, L., Quiroz-Figueroa, F. R., Meena, M., Gour, V. S., Minkina, T., Sushkova, S., et al. (2021) · Biology · doi:10.3390/biology10040267 · Cited by 994
The pentose phosphate pathway in health and disease
TeSlaa, T., Ralser, M., Fan, J., & Rabinowitz, J. D. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00863-2 · Cited by 650
Self-citationA hydride transfer complex reprograms NAD metabolism and bypasses senescence
Igelmann, S., Lessard, F., Uchenunu, O., Bouchard, J., Fernandez-Ruiz, A., Rowell, M.-C., Lopes-Paciencia, S., Papadopoli, D., Fouillen, A., Ponce, K. J., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.028 · Cited by 60
Metadata
- Authors
- Zhang, Y., Xu, Y., Lu, W., Ghergurovich, J. M., Guo, L., Blair, I. A., Rabinowitz, J. D., & Yang, X.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 33
- Issue
- 1
- Pages
- 94-109.e8
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W3097928186
- Cited by
- 96
- References
- 23
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Upregulation of Antioxidant Capacity and Nucleotide Precursor Availability Suffices for Oncogenic Transformation. https://app.cochat.ai/papers/10.1016/j.cmet.2020.10.002
- The paper
- Zhang, Y., Xu, Y., Lu, W., Ghergurovich, J. M., Guo, L., Blair, I. A., Rabinowitz, J. D., & Yang, X. (2021). Upregulation of Antioxidant Capacity and Nucleotide Precursor Availability Suffices for Oncogenic Transformation. Cell Metabolism. https://doi.org/10.1016/j.cmet.2020.10.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.